[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
January 21, 1950


Author Affiliations

Chairman, Department of Radiology, University of Illinois College of Medicine, Chicago.

JAMA. 1950;142(3):198. doi:10.1001/jama.1950.02910210054021

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  The recent newspaper publicity on the medical betatron at the University of Illinois College of Medicine is totally unauthorized and grossly exaggerated. One magazine has, in spite of warning, distorted facts to the point of absurdity.I am neither optimistic nor enthusiastic about the ability of the betatron to solve the cancer problem. In its present state it may be helpful in about 10 per cent of patients with cancer. It is not suitable for widespread cancer, terminal situations or cancers of a radiation-resistant type.Physicians having relatives or patients afflicted with cancer are urged to institute prompt and aggressive treatment by accepted methods in their own communities. We can test so few patients a month on the betatron that the Tumor Clinic in Research and Educational Hospital in Chicago can supply our needs without outside referrals.

First Page Preview View Large
First page PDF preview
First page PDF preview